Oncology Flashcards
What can PSA be raised by?
- Benign prostatic hyperplasia (BPH)
- Prostatitis (NICE recommend to postpone the PSA test for at least 1 month after treatment)
- Urinary tract infection (NICE recommend to postpone the PSA test for at least 1 month after treatment)
- Ejaculation (ideally not in the previous 48 hours)
- Vigorous exercise (ideally not in the previous 48 hours)
- Urinary retention
- Instrumentation of the urinary tract
When should one be referred urgently to urology?
‘If a hard, irregular prostate typical of a prostate carcinoma is felt on rectal examination, then the patient should be referred urgently. The PSA should be measured and the result should accompany the referral.’
Lung cancer : small cell - features?
- usually central
- arise from APUD* cells
*an acronym for
Amine - high amine content
Precursor Uptake - high uptake of amine precursors
Decarboxylase - high content of the enzyme decarboxylase - associated with ectopic ADH,
ACTH secretion - ADH → hyponatraemia
- ACTH → Cushing’s syndrome
- ACTH secretion can cause bilateral adrenal hyperplasia, the high levels of cortisol can lead to hypokalaemic alkalosis
- Lambert-Eaton syndrome: antibodies to voltage gated calcium channels causing myasthenic like syndrome
Lung cancer : small cell - Management?
- usually metastatic disease by time of diagnosis
- patients with very early stage disease (T1-2a, N0, M0) are now considered for surgery. NICE support this approach in their 2011 guidelines
- however, most patients with limited disease receive a combination of CHEMOTHERAPY and RADIOTHERAPY
patients with more extensive disease are offered palliative chemotherapy
What is the most important risk factor for developing cervical cancer?
- Human papilloma virus (HPV)
- Subtypes 16,18 & 33 are particularly carcinogenic.
Which are the non-carcinogenic subtypes of HPV? What are they associated with?
Subtypes 6 and 11
Associated with GENITAL WARTS.
What characteristics do koliocytes have?
- enlarged nucleus
- irregular nuclear membrane contour
- the nucleus stains darker than normal (hyperchromasia)
- a perinuclear halo may be seen
What are koliocytes?
Infected endocervical cells may undergo changes resulting in the development of koilocytes
What is the most common colorectal cancers?
Adenocarcinomas
Colorectal cancer screening - what is available?
- Faecal Immunochemical Test (FIT)
- Flexible sigmoidoscopy screening
At what age are people offered screening tests for colorectal cancer?
Age 55
One-off flexible sigmoidoscopy at age 55 aims to detect and treat polyps, reducing future risk of colorectal cancer
What is the FIT screening test?
Faecal Immunochemical Test (FIT) screening
- national screening programme offering screening every 2 years to all men and women aged 60 to 74 years in England. Patients aged over 74 years may request screening
- eligible patients are sent Faecal Immunochemical Test (FIT) tests through the post
- a type of faecal occult blood (FOB) test which uses antibodies that specifically recognise human haemoglobin (Hb)
- used to detect, and can quantify, the amount of human blood in a single stool sample
- patients with abnormal results are offered a colonoscopy
Why is FIT screening better than conventional FOB (faecal occult blood) tests
- advantages over conventional FOB tests is that it ONLY DETECTS HUMAN HAEMOGLOBIN, as opposed to animal haemoglobin ingested through diet
- only one faecal sample is needed compared to the 2-3 for conventional FOB tests
What is flexible sigmoidoscopy screening?
- screening for bowel cancer using sigmoidoscopy is part of the NHS screening program
- the aim (other than to detect asymptomatic cancers) is to allow the detection and treatment of POLYPS, reducing the future risk of colorectal cancer
- this is being offered to people who are 55-years-old
- NHS patient information leaflets refer to this as ‘bowel scope screening’
- patients can self-refer for bowel screening with sigmoidoscopy up to the age of 60, if the offer of routine one-off screening at age 55 had not been taken up
Endometrial cancer - risk factors
- obesity
- nulliparity
- early menarche
- late menopause
- unopposed oestrogen. The addition of a progestogen to oestrogen reduces this risk (e.g. In HRT). The BNF states that the additional risk is eliminated if a progestogen is given continuously
- diabetes mellitus
- tamoxifen
- polycystic ovarian syndrome
- hereditary non-polyposis colorectal carcinoma
Features of endometrial cancer
- POSTMENOPAUSAL BLEEDING is the classic symptom
- premenopausal women may have a change intermenstrual bleeding
- pain and discharge are UNUSUAL features
Investigations for endometrial cancer
- women >= 55 years who present with postmenopausal bleeding should be referred using the suspected cancer pathway
- first-line investigation is TRANS-VAGINAL ULTRASOUND - a normal endometrial thickness (< 4 mm) has a high negative predictive value
- hysteroscopy with endometrial biopsy
Management of endometrial cancer
- localised disease is treated with TOTAL ABDOMINAL HYSTERECTOMY WITH BILATERAL SALPINGO-OOPHOTRECTOMY. Patients with high-risk disease may have post-operative radiotherapy
- progestogen therapy is sometimes used in frail elderly women not consider suitable for surgery
What are the protective factors for endometrial cancer?
- Combined oral contraceptive pill
- Smoking
How often are faecal immunochemical tests (FIT) sent to people’s houses?
Every 2 years
What supports a diagnosis of adenocarcinoma?
- gynaecomastia (particularly associated with lung adenocarcinoma- but is an infrequent manifestation)- thought to be caused by an increased oestrogen/androgen ratio, or the tumouritself produces a substance causing hormonal change
- hypertrophic pulmonary osteoarthropathy (HPOA)
- most common lung malignancy in non-smokers
What is mesothelioma?
is a type of cancer that can develop years after exposure to asbestos
What are the paraneoplastic features of small cell carcinoma?
- ACTH - not typical, hypertension, hyperglycaemia, hypokalaemia, alkalosis and muscle weakness are more common than buffalo hump etc
- Lambert-Eaton syndrome
- Syndrome of inappropriate anti-diuretic hormone (SIADH) secretion.
What is the most likely lung cancer found in smokers?
Squamous cell carcinoma
Squamous cell carcinoma is associated with?
- Hypertrophic pulmonary oesteoarthropathy (HPOA)
- Parathyroid hormone -related protein secretion - causing hypercalcaemia, and hyperthyroidism due to ectopic thyroid stimulating hormone secretion.
Lung cancer - features
- persistent cough
- haemoptysis
- dyspnoea
- chest pain
- weight loss and anorexia
- hoarseness- seen with Pancoast tumours pressing on the recurrent laryngeal nerve
- superior vena cava syndrome
Lung cancer - Examination findings
- a fixed, MONOPHONIC wheeze may be noted
- supraclavicular lymphadenopathy or persistent cervical lymphadenopathy
- clubbing
Paraneoplastic features -Squamous cell lung cancer
- parathyroid hormone-related protein (PTH-rp) secretion causing hypercalcaemia
- clubbing
- hypertrophic pulmonary osteoarthropathy (HPOA)
- hyperthyroidism due to ectopic TSH
Paraneoplastic features of adenocarcinoma of the lungs
- gynaecomastia
- hypertrophic pulmonary osteoarthropathy (HPOA)
Complications of lung cancer
Hoarseness
Stridor
(thrombocytosis?)
What is the first line investigation in suspected prostrate cancer?
Multiparametric MRI (has replaced TRUS biopsy)
Prostate cancer - investigations
Multiparametric MRI as a first-line investigation - for clinically localised prostate cancer
- the results are reported using a 5-point Likert scale
- If the Likert scale is >=3 a multiparametric MRI-influenced prostate biopsy is offered
- If the Likert scale is 1-2 then NICE recommend discussing with the patient the pros and cons of having a biopsy.
Breast cancer management- what are the possible options (not going into detail)
The management of breast cancer depends on the staging, tumour type and patient background. It may involve any of the following:
- surgery
- radiotherapy
- hormone therapy
- biological therapy
- chemotherapy
Who is eligible for a surgical management for breast cancer?
The vast majority of patients who have breast cancer diagnosed will be offered surgery. An exception may be a very frail, elderly lady with metastatic disease who may be better managed with hormonal therapy.
Prior to surgery, the presence/absence of AXILLARY LYMPHADENOPATHY
- determines management:
women with NO palpable axillary lymphadenopathy at presentation should have a PRE-OPERATIVE AXILLARY ULTRASOUND before their primary surgery
===if positive then they should have a sentinel node biopsy to assess the nodal burden
- in patients with breast cancer who present with clinically PALPABLE lymphadenopathy, AXILLARY NODE CLEARANCE is indicated at primary surgery
- this may lead to arm lymphedema and functional arm impairment
Depending on the characteristics of the tumour women either have a WIDE-LOCAL EXCISION or a MASTECTOMY. Around two-thirds of tumours can be removed with a wide-local excision.
Women should be offered breast reconstruction to achieve a cosmetically suitable result regardless of the type of operation they have. For women who’ve had a mastectomy this may be done at the initial operation or at a later date.
Why choose a mastectomy or wide local excision? Factors about them
Mastectomy
- multifocal tumour
- central tumour
- large lesion in small breast
- DCIS >4cm (Ductal carcinoma in situ)
Wide local excision
- Solitary lesion
- Peripheral tumour
- Small lesion in large breast
- DCIS <4cm
Radiotherapy treatment in breast cancer - when it given?
- WHOLE BREAST radiotherapy is recommended AFTER a woman has had a WIDE -LOCAL EXCISION as this may reduce the risk of recurrence by around two-thirds.
- For women who’ve had a mastectomy radiotherapy is offered for T3-T4 tumours and for those with four or more positive axillary nodes
Hormonal therapy - when is it given?
breast cancer
Adjuvant hormonal therapy is offered if tumours are POSITIVE FOR HORMONE RECEPTORS.
- Tamoxifen is used in PRE- and PERI-menopausal women.
- In POST-menopausal women, AROMATASE inhibitors such as ANASTROZOLE are used for this purpose. This is important as aromatisation accounts for the majority of oestrogen production in post-menopausal women and therefore anastrozole is used for ER +ve breast cancer in this group.
What are side effects of Tamoxifen?
- an increased risk of endometrial cancer
- venous thromboembolism
- menopausal symptoms.
When is biological therapy used in the treatment of breast cancer?
The most common type of biological therapy used for breast cancer is TRASTUZUMAB (HERCEPTIN). It is only useful in the 20-25% of tumours that are HER2 positive.
Trastuzumab cannot be used in patients with a history of heart disorders.
When can trastuzumab not be used?
Patients with history of heart disease
When in chemotherapy used in the treatment of breast cancer?
CYTOTOXIC THERAPY may be used either prior to surgery (‘neoadjuvanant’ chemotherapy) to downstage a primary lesion or after surgery depending on the stage of the tumour, for example, if there is axillary node disease - FEC-D is used in this situation.
What is the treatment post breast conserving surgery for breast cancer?
Breast conserving is - wide local excision
Radiotherapy is routine following breast conserving surgery
What is the treatment for the elderly with breast cancer?
- Elderly patients may be managed using ENDOCRINE THERAPY ALONE.
- Eventually most will escape hormonal control.
- In post menopausal women oestrogen are produced by the peripheral aromatisation of androgens aromatase inhibitors are therefore the most popular agent in this age group
- E.g. of treatment - endocrine therapy using letrozole
What treatment would you give for a grade 3 tumour and axillary node metastasis in a young female with breast cancer?
- Cytotoxic chemotherapy
- Some may also add Herceptin (if they are HER2 positive)
What type of lung cancer is most commonly found near large airways?
Squamous cell lung cancer
Small cell lung cancer
What type of lung cancer is most commonly found in peripheral airways?
adenocarcinoma
What are the features of squamous cell cancer?
- typically central
- associated with parathyroid hormone-related protein (PTHrP) secretion → hypercalcaemia
- strongly associated with finger clubbing
- hypertrophic pulmonary osteoarthropathy (HPOA)
What are the features of adenocarcinoma?
- typically peripheral
- most common type of lung cancer in non-smokers, although the majority of patients who develop lung adenocarcinoma are smokers
What are the features of large cell carcinoma?
- typically peripheral
- anaplastic, poorly differentiated tumours with a poor prognosis
- may secrete β-hCG
What happens next if a routine smear shows ‘borderline changes’?
If a smear is reported as borderline or mild dyskaryosis the original sample is tested for HPV (high-risk subtypes of HPV such as 16,18 & 33):
- if HPV negative the patient goes back to routine recall
- if HPV positive the patient is referred for colposcopy
What happens next if a routine smear shows ‘moderate dyskaryosis?
Consistent with Cervical Intraepithelial smears II.
Refer for urgent colposcopy (within 2 weeks)
(Women who have been treated for CIN1, CIN2, or CIN3 should be invited 6 months after treatment for ‘test of cure’ repeat cytology in the community. )
What happens next if a routine smear shows ‘severe dyskaryosis’?
Consistent with Cervical Intraepithelial smears III.
Refer for urgent colposcopy (within 2 weeks)
(Women who have been treated for CIN1, CIN2, or CIN3 should be invited 6 months after treatment for ‘test of cure’ repeat cytology in the community)
What do you do if a routine smear comes back as ‘Inadequate’?
Repeat smear - if persistent (3 inadequate samples), assessment by colposcopy
What is the first line investigation of a testicular mass? And why?
Ultrasound
- to characterise the lesion and confirm the presence of a mass
Testicular cancer - what are the types ?
Around 95% of cases of testicular cancer are germ-cell tumours.
Non-germ cell tumours include Leydig cell tumours and sarcomas.
Germ cell tumours may essentially be divided into:
- seminomas
- non-seminomas: including embryonal, yolk sac, teratoma and choriocarcinoma
What are the risk factors for testicular cancer?
Risk factors include:
- infertility (increases risk by a factor of 3)
- cryptorchidism
- family history
- Klinefelter’s syndrome
- mumps orchitis
What are the features of testicular cancer?
- a PAINLESS LUMP is the most common presenting symptom
- pain may also be present in a minority of men
- other possible features include hydrocele, gynaecomastia
- AFP is elevated in around 60% of germ cell tumours
- LDH is elevated in around 40% of germ cell tumours
- seminomas: hCG may be elevated in around 20%
What is the management of testicular cancer?
- treatment depends on whether the tumour is a seminoma or a non-seminoma
- orchidectomy
- chemotherapy and radiotherapy may be given depending on staging and tumour type
What is the strongest risk factor for developing anal cancer?
HPV infection
Risk factors for anal cancer
- HPV infection causes 80-85% of SSCs of the anus (usually HPV16 or HPV18 subtypes).
- Anal intercourse and a high lifetime number of sexual partners increases the risk of HPV infection.
- Men who have sex with men have a higher risk of anal cancer.
- Those with HIV and those taking immunosuppressive medication for HIV are at a greater risk of anal carcinoma.
- Women with a history of cervical cancer or cervical intraepithelial neoplasia (CIN) are also at greater risk of anal cancer.
- Immunosuppressive drugs used in transplant recipients increase the risk of anal cancer.
- Smoking is also a risk factor.
What is a typical subacute onset of anal cancer?
- Perianal pain, perianal bleeding
- A palpable lesion
- Faecal incontinence
- A neglected tumour in a female may present with a rectovaginal fistula.
What are the investigations for anal cancer?
- T stage assessment: examination, including a digital rectal examination, anoscopic examination with biopsy, and palpation of the inguinal nodes.
- Imaging modalities: CT, MRI, endo-anal ultrasound and PET.
- The patient should be tested for relevant infections, including HIV.
T staging for anal cancer
TX primary tumour cannot be assessed
T0 no evidence of primary tumour
Tis carcinoma in situ
T1 tumour 2 cm or less in greatest dimension
T2 tumour more than 2 cm but not more than 5 cm in greatest dimension
T3 tumour more than 5 cm in greatest dimension
T4 tumour of any size that invades adjacent organ(s) - for example, vagina, urethra, bladder (direct invasion of the rectal wall, perirectal skin, subcutaneous tissue, or the sphincter muscle(s) - is not classified as T4)
What are the types of cervical cancer?
It may be divided into:
- squamous cell cancer (80%)
- adenocarcinoma (20%)
Features of cervical cancer
May be detected during routine cervical cancer screening
- abnormal vaginal bleeding: postcoital, intermenstrual or postmenopausal bleeding
- vaginal discharge
Risk factors of cervical cancer
- Human papillomavirus (HPV), particularly serotypes 16,18 & 33 is by far the most important factor in the development of cervical cancer.
Other risk factors include:
- smoking
- human immunodeficiency virus
- early first intercourse, many sexual partners
- high parity
- lower socioeconomic status
- combined oral contraceptive pill
What is the mechanism by which HPV causes cervical cancer?
- HPV 16 & 18 produces the oncogenes E6 and E7 genes respectively
- E6 inhibits the p53 tumour suppressor gene
- E7 inhibits RB suppressor gene
What is a complication of acute urinary retention? How would you check for this?
A post renal cause - ACUTE KIDNEY INJURY
Check serum creatinine
also for retention - aCatheter is inserted.
- It will be important to monitor fluid balance carefully during the next 48 hours: some patients develop a post-obstructive diuresis after insertion of the catheter.
What are the risk factors of prostate cancer ?
- increasing age
- obesity
- Afro-Caribbean ethnicity
- family history: around 5-10% of cases have a strong family history
Features of prostate cancer?
Localised prostate cancer is often ASYMPTOMATIC. This is partly because cancers tend to develop in the periphery of the prostate and hence don’t cause obstructive symptoms early on.
Possible features include:
- bladder outlet obstruction: hesitancy, urinary retention
- haematuria, haematospermia
- pain: back, perineal or testicular
- digital rectal examination: asymmetrical, hard, nodular enlargement with loss of median sulcus
Where does prostate cancer metastasise to?
bone
An unresolving left varicocele - what you think is the possible cause?
Renal tract cancer - this is due to the embryological anatomy linking the left renal vein and the left testicular vein
What is the tumour marker in pancreatic cancer?
CA19-9
What is the tumour marker for ovarian cancer?
CA125
What is the tumour marker for testicular cancer?
Beta HCG
What is CA19-9 used for?
Used a s a tumour marker in pancreatic cancer
What is CA125 used for?
Used as a tumour marker for ovarian cancer
What is Beta HCG used for?
Used as a tumour marker for testicular cancer
What is renal cell cancer associated with?
- more common in middle-aged - men
- smoking
- von Hippel-Lindau syndrome
- tuberous sclerosis
(incidence of renal cell cancer is only slightly increased in patients with autosomal dominant polycystic kidney disease)
Features of renal cell cancer?
- classical triad: haematuria, loin pain, abdominal mass
- pyrexia of unknown origin
- left varicocele (due to occlusion of left testicular vein)
- endocrine effects: may secrete erythropoietin (polycythaemia), parathyroid hormone (hypercalcaemia), renin, ACTH
- 25% have metastases at presentation
- paraneoplastic hepatic dysfunction syndrome. Also known as Stauffer syndrome. Typically presents as cholestasis/hepatosplenomegaly. It is thought to be secondary to increased levels of IL-6
Management of renal cell cancer?
- for confined disease - a partial or total NEPHRECTOMY depending on the tumour size
- ALPHA -INTERFERON and INTERLEUKIN-2 have been used to reduce tumour size and also treat patients with metatases
- receptor tyrosine kinase inhibitors (e.g. sorafenib, sunitinib) have been shown to have superior efficacy compared to interferon-alpha